Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index; 6 of the 61 sources its claims cite were checked for support.
Abstract
Mounting evidence suggests that aberrations in immune-inflammatory pathways contribute to the pathophysiology of major depressive disorder (MDD), and individuals with MDD may have elevated levels of predominantly pro-inflammatory cytokines and C-reactive protein. In addition, previous meta-analyses suggest that antidepressant drug treatment may decrease peripheral levels of interleukin-1 beta (IL-1β) and IL-6. Recently, several new studies examining the effect of antidepressants on these cytokines have been published, and so we performed an updated meta-analysis of studies that measured peripheral levels of cytokines and chemokines during antidepressant treatment in patients with MDD. The PubMed/MEDLINE, EMBASE, and PsycInfo databases were searched from inception through March 9, 2017. Forty-five studies met inclusion criteria (N = 1517). Peripheral levels of IL-6, tumor necrosis factor-alpha (TNF-α), IL-1β, IL-10, IL-2, IL-4, interferon-γ, IL-8, the C-C motif ligand 2 chemokine (CCL-2), CCL-3, IL-1 receptor antagonist, IL-13, IL-17, IL-5, IL-7, and the soluble IL-2 receptor were measured in at least three datasets and thus were meta-analyzed. Antidepressant treatment significantly decreased peripheral levels of IL-6 (Hedges g = −0.454, P <0.001), TNF-α (g = −0.202, P = 0.015), IL-10 (g = −0.566, P = 0.012), and CCL-2 (g = −1.502, P = 0.006). These findings indicate that antidepressants decrease several markers of peripheral inflammation. However, this meta-analysis did not provide evidence that reductions in peripheral inflammation are associated with antidepressant treatment response although few studies provided separate data for treatment responders and non-responders.
Overview
CoChat Summary
TL;DR
This updated systematic review and meta-analysis of 45 studies (N=1517) found that antidepressant drug treatment significantly decreased peripheral levels of IL-6, TNF-α, IL-10, and CCL-2 in patients with major depressive disorder. Reductions in peripheral inflammation were not consistently associated with antidepressant treatment response, and baseline TNF-α did not differ between responders and non-responders.
Key findings
- Antidepressant treatment significantly reduced peripheral IL-6 (Hedges g = -0.454, P < 0.001), TNF-α (g = -0.202, P = 0.015), IL-10 (g = -0.566, P = 0.012), and CCL-2 (g = -1.502, P = 0.006).
- IL-1β was not significantly reduced after antidepressant treatment (g = -0.255, P = 0.176; 15 studies; N=331), and 11 additional immune variables meta-analyzed were not significantly altered overall.
- Composite measures suggested a significant reduction in cytokines/chemokines predominantly secreted by M1 macrophages (g = -0.35, P < 0.001), whereas TH1, TH2, and TReg composites were not significantly altered.
- Treatment-response analyses were non-significant: TNF-α responders g = -0.346, k=8, P=0.115; TNF-α non-responders g = 0.049, k=7, P=0.590; IL-6 responders g = -0.222, k=4, P=0.480; IL-6 non-responders g = -0.010, k=4, P=0.964. Baseline TNF-α and IL-8 also did not differ between responders and non-responders (TNF-α g = 0.248, k=7, P=0.353; IL-8 g = -0.082, k=3, P=0.595).
Methods
- Systematic review and within-group meta-analysis following PRISMA; PubMed/MEDLINE, EMBASE, and PsycInfo were searched from inception through March 9, 2017; 45 original studies met inclusion criteria (N=1517). Eligible studies measured peripheral cytokine/chemokine levels in adults (age ≥18) meeting DSM or ICD criteria for MDD, before and after approved antidepressant treatment, with follow-up ≥4 weeks (mean follow-up 7.6 weeks, SD=3.3, range 4–20).
- Data extraction included means, variance estimates, and sample sizes; mediators with at least 3 datasets were meta-analyzed. Effect sizes were estimated as Hedges’s g with 95% CIs using random-effects models (DerSimonian and Laird); heterogeneity was assessed with Cochran Q and I²; publication bias was assessed with funnel plots, Egger’s test, trim-and-fill, and fail-safe N; subgroup and random-effects meta-regression, sensitivity, and cumulative meta-analyses were also performed.
- Methodological quality was assessed with 7 parameters; quality scores ranged from 2 to 7 (median: 4).
Limitations
- The paper states that some potential sources of heterogeneity could not be explored due to lack of data, including BMI for several cytokines/chemokines and smoking data; methodological quality of included studies varied; melancholic versus atypical depression could not be contrasted; and assay standardization/technical challenges may have contributed to heterogeneity.
- The paper also notes that CCL-2 findings should be interpreted cautiously because the effect did not survive sensitivity analysis, and TNF-α sensitivity analysis showed that exclusion of two individual studies rendered the effect non-significant.
- Evident from the text: heterogeneity was large for many estimates, including IL-6 (I²=84.7%), TNF-α (I²=80.0%), IL-1β (I²=92.0%), and CCL-2 (I²=96.0%), and few studies provided separate responder/non-responder data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 1 Not valid · 44 Not checked · 96 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Accumulating evidence indicates that activation of immune-inflammatory pathways may contribute to the development of major depressive disorder (MDD) in at least a sub-set of patients [1,2].”
§ Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis > Introduction
What the sources say
- Supportedcites [1] Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16(1):22–34. doi: 10.1038/nri.2015.5 source
The “Increased inflammation and the risk for depression” section says inflammation may cause depression in certain subgroups and cites longitudinal evidence that elevated inflammatory markers predict later depressive symptoms. The claim’s cautious wording and subset qualifier match the review’s conclusions. (LLM, conf=0.94)
- Supportedcites [2] Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46–56. doi: 10.1038/nrn2297 source
The Future directions passage states that inflammation increases the risk of major depressive episodes. The discussion of inflammatory biomarkers notes that they are not elevated in all clinically depressed patients, consistent with the claim’s qualification that this may apply to a subset. (LLM, conf=0.93)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Therefore, it is possible that the observed effects of standard antidepressants observed herein (i.e., an overall decrease in predominantly inflammatory cytokines and chemokines) may not be the main mechanism contributing to the therapeutic benefits of these drugs [39].”
§ Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis > Discussion
What the sources say
- Supportedcites [39] Miller AH, Haroon E, Felger JC (2016) Therapeutic implications of brain-immune interactions: treatment in translation. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. doi: 10.1038/npp.2016.167 source
The citing authors identify the decrease in cytokines and chemokines as an effect they observed themselves. In “Immunological Mechanisms” (page not available), the source says the response to certain antidepressants may partly depend on inflammatory-cytokine induction and cautions against suppressing cytokines’ neuroregulatory functions. That supports the citing sentence’s cautious suggestion that reducing inflammatory signals may not be the main therapeutic mechanism. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and levels decreased only in studies where treatment time was longer than the median (Table S5, available online).”
§ Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis > Interleukin-6
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Levels of TNF-α were significantly lower after antidepressant treatment (23 studies; N=797).The ES estimate was small (Hedge's g = -0.202;P=0.015) (Table 1; Figure 2B).”
§ Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis > Interleukin-6
plainstates a causen = 797 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Antidepressant treatment significantly reduced IL-6 levels with a moderate ES (Hedge's g = -0.454)(Table 1; Figure 2A).”
§ Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis > Interleukin-6
plainstates a causen = 722- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
71 more claims
Create a free account to see all 145 claims and to verify the 55 references still open.
- It may state two separate claims as one. 26
- Probably not a substantial claim. 50
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“such positive results have not been obtained by all studies”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As peripheral levels of IL-6, IL-10, IL-12, IL13, and TNF-α have been shown to be significantly elevated and IFN-γ plasma concentrations significantly lower in patients with depression compared to healthy controls in meta-analytic research (2), one could think that cytokines qualify as a biomarker of depression.”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“peripheral levels of interleukin (IL)-6, IL-10, IL-12, IL-13, and tumor necrosis factor (TNF)-α are elevated”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Treatment with certain antidepressants appears to decrease peripheral levels of IL-6, IL-10, and TNF-α.”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [2]
In the citing paper
“peripheral levels of interleukin (IL)-6, IL-10, IL-12, IL-13, and tumor necrosis factor (TNF)-α are elevated”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [2]
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · cited 1×
“To assess publication bias, we inspected a funnel plot graph for asymmetry, and calculated the Egger’s regression test for funnel plot asymmetry [26].”
MethodMeta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164 · cited 1×
“We complied with the Preferred Reported Items for Systematic Reviews and Meta-analysis (PRISMA) statement [15].”
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099 · cited 1×
“mate the ES adjusting to publication bias [27], while the fail-safe N (i.”
The file drawer problem and tolerance for null results.
Rosenthal, R. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.3.638 · Cited by 9,068 · cited 1×
“to turn significant ES non-significant [28].”
Estimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 1×
“Accumulating evidence indicates that activation of immuneinflammatory pathways may contribute to the development of major depressive disorder (MDD) in at least a subset of patients [1, 2].”
Research works printed but not linked: 1
- World Health Organization (1993) The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. World Health Organization, Geneva
Cited by
The Bidirectional Relationship of Depression and Inflammation: Double Trouble
Beurel, E., Toups, M., & Nemeroff, C. B. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.002 · Cited by 2,136
“The largest meta-analysis of 45 studies representing 1,517 MDD patients revealed that antidepressant treatment significantly decreases peripheral levels of IL-6, TNF, IL-10, and CCL2, but these are not associated with treatment response (Köhler et al., 2018).”
BackgroundLong covid—mechanisms, risk factors, and management
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021) · BMJ · doi:10.1136/bmj.n1648 · Cited by 1,655
Mechanisms and treatment of late-life depression
Alexopoulos, G. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0514-6 · Cited by 592
Liu, J. J., Wei, Y. B., Strawbridge, R., Bao, Y., Chang, S., Shi, L., Que, J., Gadad, B. S., Trivedi, M. H., Kelsoe, J. R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0474-5 · Cited by 429
Lee, Y., Ragguett, R.-M., Mansur, R. B., Boutilier, J. J., Rosenblat, J. D., Trevizol, A., Brietzke, E., Lin, K., Pan, Z., Subramaniapillai, M., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.073 · Cited by 408
Metadata
- Authors
- Köhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., Herrmann, N., Raison, C. L., Miller, B. J., Lanctôt, K. L., & Carvalho, A. F.
- Affiliations
- Universidade de Fortaleza (BR)
- King's College London (GB)
- Universidade Estadual de Londrina (BR)
- University of Padua (IT)
- Deakin University (AU)
- Universidade Federal do Rio Grande do Sul (BR)
- Universidade de São Paulo (BR)
- University of Toronto (CA)
- University of Wisconsin–Madison (US)
- Augusta University (US)
- ORCID
- Venue
- Molecular Neurobiology
- Published
- 2017-06-13
- Volume
- 55
- Issue
- 5
- Pages
- 4195-4206
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2624751168
- Semantic Scholar
- 7dba48bbdd5bebd7cbc2a9176a65c4f837381641
- Cited by
- 449
- References
- 57
- Citations by year
- 2026: 14 · 2025: 37 · 2024: 44 · 2023: 53 · 2022: 65 · 2021: 86 · 2020: 45 · 2019: 59 · 2018: 39 · 2017: 7
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- green
- kclpure.kcl.ac.uk
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (unspecified)
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion, cc-by-nc-nd)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by-nc-nd)
- Funders
- National Institute for Health and Care Research (ICA-CL-2017-03-001, NIHR-INF-0685)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, antidepressant treatment, cytokines, chemokines, peripheral inflammation, interleukin-6, TNF-α, IL-10, MCP-1, immune-inflammatory pathways, treatment response
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Depressive Disorder, Major, Humans, Treatment Outcome, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1007/s12035-017-0632-1
- The paper
- Köhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., Herrmann, N., Raison, C. L., Miller, B. J., Lanctôt, K. L., & Carvalho, A. F. (2017). Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis. Molecular Neurobiology. https://doi.org/10.1007/s12035-017-0632-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.